NEW YORK (GenomeWeb) – Microbial genetics analysis firm OpGen on Wednesday filed with the US Securities and Exchange Commission to publicly sell up to $10 million in stock and warrants.

The company did not provide an offering price or specify how many shares and warrants it plans to sell. During mid-morning trading on the Nasdaq, shares of OpGen were up about 1 percent at $.67. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.